Clovis Oncology (CLVS) Stock Rockets On FDA Approval

Clovis Oncology CLVS Stock News

Clovis Oncology Inc (NASDAQ: CLVS) is running for the top in the market this morning, trading on gains of more than 13% before the bell. The gains come after the company announced that it has received an FDA approval. Here’s what’s going on: Stop wasting your time! Start finding winning trades in minutes with Trade … Read more